Suppr超能文献

通过肠道和静脉同时输注[2H3]-亮氨酸和[13C]-亮氨酸的亮氨酸动力学。

Leucine kinetics from [2H3]- and [13C]leucine infused simultaneously by gut and vein.

作者信息

Hoerr R A, Matthews D E, Bier D M, Young V R

机构信息

Laboratory of Human Nutrition, School of Science, Massachusetts Institute of Technology, Cambridge 02139.

出版信息

Am J Physiol. 1991 Jan;260(1 Pt 1):E111-7. doi: 10.1152/ajpendo.1991.260.1.E111.

Abstract

In amino acid tracer kinetic studies of the fed state, ingested amino acid may be taken up during its initial transit through splanchnic tissues and thus not enter the plasma compartment where tracer is infused. To investigate this possibility, adult human subjects received simultaneous intravenous (iv) and intragastric (ig) leucine tracer infusions, first during a postabsorptive (PA) 4-h primed continuous ig infusion of L-[1-13C]-leucine and L-[5,5,5-2H3]leucine iv, followed on a separate day by a fed infusion, in which an ig infusion of a liquid formula was started 2 h before the tracer infusion and continued throughout the tracer study. Subjects were accustomed to a constant experimental diet supplying 1.5 g protein.kg-1.day-1 and 41-45 kcal.kg-1.day-1 for 7 and 12 days before the PA and fed studies, respectively. For the PA study, plasma enrichment for the ig tracer was 3.34 +/- 0.27 (SE) mol + excess and for the iv tracer it was 4.18 +/- 0.10 (P less than 0.02). Enrichments of alpha-keto-isocaproic acid (KIC) were 3.24 +/- 0.16 (ig) and 3.02 +/- 0.14 (iv), respectively [not significant (NS)]. For the fed study, plasma leucine enrichment for the ig tracer was 2.15 +/- 0.14 and for the iv tracer was 2.84 +/- 0.09 (P less than 0.02). KIC enrichments were 2.02 +/- 0.08 (ig) and 2.24 +/- 0.08 (iv), respectively (NS). In the PA study, the ratio of the plasma leucine enrichments for the ig and iv tracers was 0.80 +/- 0.06 and in the fed experiment, 0.76 +/- 0.05, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在进食状态下的氨基酸示踪动力学研究中,摄入的氨基酸在其最初通过内脏组织的过程中可能会被摄取,因此不会进入注入示踪剂的血浆区室。为了研究这种可能性,成年人类受试者同时接受静脉内(iv)和胃内(ig)亮氨酸示踪剂输注,首先在吸收后(PA)阶段,进行4小时的L-[1-¹³C]-亮氨酸胃内预充连续输注,并静脉内输注L-[5,5,5-²H₃]亮氨酸,在另一天进行进食状态下的输注,即在示踪剂输注前2小时开始胃内输注液体配方,并在整个示踪剂研究过程中持续进行。受试者在PA和进食状态研究前分别习惯了供应1.5g蛋白质·kg⁻¹·天⁻¹和41 - 45kcal·kg⁻¹·天⁻¹的恒定实验饮食7天和12天。对于PA研究,胃内示踪剂的血浆富集为3.34±0.27(SE)mol + 过量,静脉内示踪剂为4.18±0.10(P < 0.02)。α-酮异己酸(KIC)的富集分别为3.24±0.16(胃内)和3.02±0.14(静脉内)[无显著差异(NS)]。对于进食状态研究,胃内示踪剂的血浆亮氨酸富集为2.15±0.14,静脉内示踪剂为2.84±0.09(P < 0.02)。KIC富集分别为2.02±0.08(胃内)和2.24±0.08(静脉内),分别(无显著差异)。在PA研究中,胃内和静脉内示踪剂的血浆亮氨酸富集比为0.80±0.06,在进食状态实验中为0.76±0.05。(摘要截断于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验